OhioHealth Partners with 产颈辞惭茅谤颈别耻虫 as Newest Global Antimicrobial Stewardship Center of Excellence
产颈辞惭茅谤颈别耻虫 (OTC:BMXXY) has designated OhioHealth as the nation's newest Antimicrobial Stewardship (AMS) Center of Excellence, making it the 4th institution in the country and the first regional healthcare system to receive this recognition. The partnership aims to combat antimicrobial resistance (AMR), which is predicted to surpass cancer as the leading cause of death globally by 2050.
Through this collaboration, 产颈辞惭茅谤颈别耻虫 will provide expertise in advanced diagnostic technologies, IT and lab automation, along with training and quality management support. The OhioHealth Microbiology Laboratory will focus on early and accurate diagnostic testing to guide appropriate antibiotic use and improve patient outcomes across more than 50 of Ohio's 88 counties.
产颈辞惭茅谤颈别耻虫 (OTC:BMXXY) ha nominato OhioHealth come il nuovo Centro di Eccellenza per la Stewardship Antimicrobica (AMS) negli Stati Uniti, diventando la 4陋 struttura nel paese e il primo sistema sanitario regionale a ottenere questo riconoscimento. La collaborazione mira a contrastare la resistenza antimicrobica (AMR), stimata che potrebbe superare il cancro come principale causa di morte a livello mondiale entro il 2050.
Con questo partenariato, 产颈辞惭茅谤颈别耻虫 metter脿 a disposizione competenze in tecnologie diagnostiche avanzate, IT e automazione di laboratorio, oltre a supporto nella formazione e nella gestione della qualit脿. Il Laboratorio di Microbiologia di OhioHealth si concentrer脿 su test diagnostici precoci e accurati per orientare l'uso appropriato degli antibiotici e migliorare gli esiti clinici in oltre 50 delle 88 contee dell'Ohio.
产颈辞惭茅谤颈别耻虫 (OTC:BMXXY) ha designado a OhioHealth como el nuevo Centro de Excelencia en Manejo de Antimicrobianos (AMS) del pa铆s, convirti茅ndose en la 4.陋 instituci贸n en Estados Unidos y el primer sistema sanitario regional en recibir este reconocimiento. La asociaci贸n busca combatir la resistencia antimicrobiana (AMR), prevista para superar al c谩ncer como principal causa de muerte a nivel mundial para 2050.
A trav茅s de esta colaboraci贸n, 产颈辞惭茅谤颈别耻虫 aportar谩 experiencia en tecnolog铆as diagn贸sticas avanzadas, TI y automatizaci贸n de laboratorio, as铆 como apoyo en capacitaci贸n y gesti贸n de calidad. El Laboratorio de Microbiolog铆a de OhioHealth se enfocar谩 en pruebas diagn贸sticas tempranas y precisas para orientar el uso adecuado de antibi贸ticos y mejorar los resultados en pacientes en m谩s de 50 de los 88 condados de Ohio.
产颈辞惭茅谤颈别耻虫 (OTC:BMXXY)電� 鞓ろ晿鞚挫槫項姢(OhioHealth)毳� 氙戈淡鞚� 靸堧鞖� 頃窢鞝� 甏毽�(AMS) 鞖办垬靹柬劙搿� 歆鞝曧枅鞙茧┌, 鞚措姅 氙戈淡 雮� 4氩堨Ц 旮瓣磤鞚挫瀽 觳� 歆鞐� 鞚橂 鞁滌姢韰�鞙茧靹滌潣 靹标臣鞛呺媹雼�. 鞚� 韺岉姼雱堨嫮鞚 頃儩鞝� 雮挫劚(AMR)鞐� 雽鞚戫晿電� 瓴冹潉 氇╉憸搿� 頃橂┌, AMR鞚 2050雲勱箤歆 鞎旍潉 鞝滌箻瓿� 鞝� 靹戈硠 靷 鞗愳澑 1鞙勱皜 霅� 瓴�鞙茧 鞓堨浮霅╇媹雼�.
鞚措矆 順戨牓鞚� 韱淀暣 产颈辞惭茅谤颈别耻虫電� 觳嫧 歆勲嫧旮办垹, IT 氚� 鞁ろ棙鞁� 鞛愲彊頇旍棎 雽頃� 鞝勲歆鞁濌臣 甑愳湣 氚� 頀堨甏毽� 歆鞗愳潉 鞝滉车頃� 鞓堨爼鞛呺媹雼�. 鞓ろ晿鞚挫槫項姢 氙胳儩氍柬暀 鞁ろ棙鞁れ潃 臁瓣赴 鞝曧檿頃� 歆勲嫧瓴靷棎 欤茧牓頃橃棳 鞝侅爤頃� 頃儩鞝� 靷毄鞚� 鞎堧偞頃橁碃, 鞓ろ晿鞚挫槫鞚� 88臧� 甑� 臧鞖措嵃 50瓿� 鞚挫儊鞐愳劀 頇橃瀽 旃橂 靹标臣毳� 臧滌劆頃� 瓴冹瀰雼堧嫟.
产颈辞惭茅谤颈别耻虫 (OTC:BMXXY) a d茅sign茅 OhioHealth comme le nouveau Centre d'Excellence en Antimicrobial Stewardship (AMS) du pays, en faisant la 4e institution aux 脡tats鈥慤nis et le premier syst猫me de soins r茅gional 脿 recevoir cette distinction. Le partenariat vise 脿 lutter contre la r茅sistance aux antimicrobiens (AMR), qui devrait d茅passe r le cancer comme principale cause de d茅c猫s dans le monde d'ici 2050.
Dans le cadre de cette collaboration, 产颈辞惭茅谤颈别耻虫 apportera son expertise en technologies diagnostiques avanc茅es, en informatique et automatisation de laboratoire, ainsi qu'un soutien en formation et gestion de la qualit茅. Le laboratoire de microbiologie d'OhioHealth se concentrera sur des tests diagnostiques pr茅coces et pr茅cis pour guider l'utilisation appropri茅e des antibiotiques et am茅liorer les r茅sultats pour les patients dans plus de 50 des 88 comt茅s de l'Ohio.
产颈辞惭茅谤颈别耻虫 (OTC:BMXXY) hat OhioHealth als neues Antimikrobielles Stewardship (AMS) Center of Excellence in den USA benannt und damit die 4. Institution im Land sowie das erste regionale Gesundheitssystem ausgezeichnet. Die Partnerschaft zielt darauf ab, antimikrobielle Resistenz (AMR) zu bek盲mpfen, die voraussichtlich bis 2050 Krebs als h盲ufigste Todesursache weltweit 眉bertreffen wird.
Im Rahmen der Zusammenarbeit stellt 产颈辞惭茅谤颈别耻虫 Expertise in fortschrittlichen Diagnosetechnologien, IT und Laborautomatisierung sowie Unterst眉tzung bei Schulung und Qualit盲tsmanagement bereit. Das Mikrobiologielabor von OhioHealth wird sich auf fr眉he und pr盲zise Diagnostik konzentrieren, um den angemessenen Einsatz von Antibiotika zu steuern und die Patientenergebnisse in mehr als 50 der 88 Countys von Ohio zu verbessern.
- Recognition as the 4th AMS Center of Excellence in the US validates OhioHealth's leadership in patient care
- Partnership extends advanced diagnostic capabilities across 50+ Ohio counties
- Collaboration aims to reduce healthcare costs through optimized antibiotic use and decreased hospital stays
- None.
OhioHealth is only the 4th to receive the designation in the country, and the first regional healthcare system.
The 产颈辞惭茅谤颈别耻虫 initiative represents a unique set of health systems worldwide that share the same commitment as 产颈辞惭茅谤颈别耻虫 鈥� to improve AMS and slow the spread of antimicrobial resistance (AMR), a growing global public health threat.听This partnership recognizes the critical role of the laboratory in driving data-informed diagnostic practices to enhance patient care, advance infectious disease management, and accelerate the fight against AMR.听OhioHealth is the first regional healthcare system in the AMS Center of Excellence network, covering more than 50 of the 88 counties in the state of
This partnership illustrates OhioHealth's commitment to setting the national standard on patient safety and positive outcomes. Leaning into its core values of excellence and stewardship, this collaboration supports the overall mission to improve the health of those OhioHealth serves through exceptional healthcare for all.
"OhioHealth is a national leader, providing exceptional, high-quality care for each patient we have the honor of serving," said Andrea K. Smith, M.S., MB(ASCP)CM OhioHealth Senior Director, Laboratory Services.听"For our system microbiology laboratory to be recognized as an Antimicrobial Stewardship (AMS) Center of Excellence by 产颈辞惭茅谤颈别耻虫, it serves as validation for what we have passionately worked to achieve. We always put patients at the center of everything we do. By utilizing innovative technologies and best practices, we will continue to lead, ensuring our patients have the best possible outcomes."
No one is safe from AMR. By 2050, AMR is predicted to surpass cancer as the leading cause of death globally.1 Early and accurate diagnostic testing, the mission of the OhioHealth Microbiology Laboratory, plays a pivotal role in guiding appropriate antibiotic use, reducing unnecessary prescriptions, and improving patient outcomes. Economically, diagnostics can reduce healthcare costs by minimizing the use of broad-spectrum antibiotics and, most importantly, decreasing hospital stays and readmissions.
"Diagnostics are among the most powerful tools we have in the fight against AMR," said Jennifer Zinn, 产颈辞惭茅谤颈别耻虫 Executive Vice President of Clinical Operations. "Advancing AMS requires collaboration across the entire healthcare ecosystem鈥攆rom clinicians, lab professionals, pharmacists, and beyond. We're honored to welcome OhioHealth to this global movement of forward-thinking health systems. By leveraging our collective expertise and embracing diagnostics-driven stewardship, we can accelerate meaningful change, harness innovation, and ultimately help improve patient outcomes."
Through the partnership, 产颈辞惭茅谤颈别耻虫 will provide its expertise in advanced diagnostic technologies, IT and lab automation, as well as training and quality management support. A dedicated 产颈辞惭茅谤颈别耻虫 Center of Excellence team will support OhioHealth with its unique AMS initiatives to optimize these high-value solutions to improve patient care and mitigate the spread of AMR.
ABOUT GLOBAL ANTIMICROBIAL STEWARDSHIP AND AMS CENTERS OF EXCELLENCE
In 2021, 产颈辞惭茅谤颈别耻虫 established the Antimicrobial Stewardship Centers of Excellence program to bring attention to the threat of antimicrobial resistance and to accelerate the impact that infectious diseases diagnostics have in facilitating antimicrobial stewardship and better patient care. OhioHealth is the fourth
According to a landmark study published in The Lancet in 2022, as of 2019, an estimated 4.95 million annual deaths were associated with bacterial AMR, with 1.27 million deaths directly attributable to it.2 In the
To learn more about the AMS Centers of Excellence program, visit .
References:
- O'Neill, Jim, Tackling drug-resistant infections globally: Final report and recommendations. Review on Antimicrobial Resistance.
London, UK ., 2016 May - Murray, Christopher J L聽et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet. 2022 Feb.
- Amin VP, Dhanani M, Patel J, Dhawan A, Mahesh G, Chenna VSH, Kyada S, Dekhne A, Desai HD. 2233. Burden of Bacterial Antimicrobial Resistance in
United States in 2019: A Systematic Analysis. Open Forum Infect Dis. 2023 Nov 27;10(Suppl 2): ofad500.1855.
ABOUT BIOM脡RIEUX
Pioneering Diagnostics
A world leader in the field of 颈苍听惫颈迟谤辞 diagnostics for 60 years, 产颈辞惭茅谤颈别耻虫 is present in 45 countries and serves more than 160 countries with the support of a large network of distributors. In 2024, revenues reached
产颈辞惭茅谤颈别耻虫 is listed on the Euronext Paris stock market.
Symbol: BIM 鈥� ISIN Code: FR0013280286
Reuters: BIOX.PA/Bloomberg: BIM.FP
Corporate website:
ABOUT OHIOHEALTH
Based in
Serving its communities since 1891, OhioHealth is a family of 35,000 associates, physicians and volunteers, and a network of 16 hospitals, three joint-venture hospitals, 200+ ambulatory sites and other health services spanning a 50-county area. It has been recognized by FORTUNE as one of the "100 Best Companies to Work For" 15 times since 2007. For more information, visit聽.听
View original content to download multimedia:
SOURCE 产颈辞惭茅谤颈别耻虫; OhioHealth